Unique Collaboration Between TB Alliance And Tibotec to Accelerate Tuberculosis Drug Development
[Seattle, WA] A new landmark collaboration between the Global Alliance for TB Drug Development (TB Alliance) a not-for-profit, product development
[Seattle, WA] A new landmark collaboration between the Global Alliance for TB Drug Development (TB Alliance) a not-for-profit, product development
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of
Global Health Technologies Coalition receives funding to encourage new health solutions for the developing world Washington, DC, USA, May 15,
The discovery of new oral treatments for Tuberculosis (TB), which could save millions of lives in developing countries, will receive
The Global Alliance for TB Drug Development (TB Alliance) and Rutgers, The State University of New Jersey announced a collaboration
The Global Alliance for TB Drug Development (TB Alliance) and sanofi-aventis announced today that they have entered into a collaboration
The Global Alliance for TB Drug Development (TB Alliance), a public-private product-development partnership leading the development of new and affordable
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accelerating the discovery and development of
The Global Alliance for TB Drug Development (TB Alliance) and the Novartis Institute for Tropical Diseases (NITD) announced today a